17 patients ( age 15-58 years ) with refractory acute leukaemia ( 14 aml , 3 all ) were treated with high dose cytosine arabinoside ( arac ) at a dose of 3000 mg/m2 , twice daily for 6 d ( 13 patients with arac alone , 4 patients with arac and doxorubicin ) .
C0023467
aml
C0013089
doxorubicin